ALLEGRA CONWAY: Open Payments
NPI 1154969905 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 25 payments from 12 companies in 2025. Trend: 2023 $181 · 2024 $836 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 6 | $204 |
| Novo Nordisk Inc | 1 | $119 |
| Astellas Pharma US Inc | 3 | $84 |
| ViiV Healthcare Company | 2 | $69 |
| Biogen, Inc. | 3 | $67 |
| MILLICENT US INC | 3 | $66 |
| Evofem Biosciences, Inc. | 2 | $38 |
| PFIZER INC. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $23 |
Products named: BIJUVA, Wegovy, Veozah, APRETUDE, ZURZUVAE, FEMLYV, Phexxi, ABRYSVO.
Industry payments across CA — which companies pay providers there.
